Bank of New York Mellon Corp - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,354
-42.2%
17,6070.0%0.00%
Q2 2023$43,841
-15.2%
17,607
-8.7%
0.00%
Q1 2023$51,708
-50.6%
19,2940.0%0.00%
Q4 2022$104,766
-56.9%
19,294
-1.0%
0.00%
Q3 2022$243,000
+215.6%
19,497
+24.8%
0.00%
Q2 2022$77,000
-92.2%
15,625
-88.0%
0.00%
Q1 2022$990,000
-25.4%
130,270
+0.2%
0.00%
Q4 2021$1,327,000
-21.1%
129,969
+3.8%
0.00%
Q3 2021$1,681,000
-33.3%
125,250
+9.1%
0.00%
Q2 2021$2,520,000
-19.9%
114,826
-12.2%
0.00%
-100.0%
Q1 2021$3,146,000
+32.9%
130,767
-0.6%
0.00%0.0%
Q4 2020$2,367,000
+46.2%
131,535
-6.2%
0.00%
Q3 2020$1,619,000
-52.7%
140,215
-0.6%
0.00%
-100.0%
Q2 2020$3,421,000
+132.2%
141,021
+5.5%
0.00%
Q1 2020$1,473,000
-58.5%
133,726
-0.4%
0.00%
-100.0%
Q4 2019$3,549,000
+17.8%
134,301
+1.5%
0.00%0.0%
Q3 2019$3,013,000
-27.3%
132,277
-2.1%
0.00%0.0%
Q2 2019$4,144,000
-77.6%
135,144
-87.9%
0.00%
-80.0%
Q1 2019$18,498,000
-11.1%
1,114,325
+2.5%
0.01%
-28.6%
Q4 2018$20,814,000
-68.6%
1,086,910
-14.1%
0.01%
-58.8%
Q3 2018$66,193,000
+20.6%
1,265,882
+0.2%
0.02%
+13.3%
Q2 2018$54,890,000
+1774.0%
1,262,991
+1497.7%
0.02%
+1400.0%
Q1 2018$2,929,000
+403.3%
79,051
+169.4%
0.00%
Q4 2017$582,000
+2.5%
29,341
+28.4%
0.00%
Q3 2017$568,00022,8580.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders